Aurigene Discovery Technologies Limited
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Aurigene Discovery Technologies Limited
RECRUITINGPhase 2NCT06760702
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients with Colorectal,...
This is an open-label, multicentre, randomized, Phase II study and will be conducted with co-primary objectives of the study are to assess the efficacy of AUR109, as measured by...
Sponsor: Aurigene Discovery Technologies LimitedEnrolling: 905 locations
Ovarian CancerColorectal CancerRenal Cancer
RECRUITINGPhase 1NCT06761586
A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)
This is a multicenter, open-label, Phase 1 study of AUR104 in adult patients with select Relapsed/Refractory (R/R) Lymphoid Malignancies. The main objective of the study is to...
Sponsor: Aurigene Discovery Technologies LimitedEnrolling: 425 locations
Select Relapsed/Refractory Lymphoid Malignancies
RECRUITINGPhase 1 / Phase 2NCT07040059
A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium...
The study will have a dose escalation part (Phase 1b) and a randomized part (Phase 2). In Phase 1b, patients diagnosed with advanced HER2 positive gastric/gastroesophageal...
Sponsor: Aurigene Discovery Technologies LimitedEnrolling: 188 locations
HER 2 Positive Gastric CancerGastroesophageal Junction Adenocarcinoma